|
18 Jul 2007 |
Secondary endpoints of phase II/III study confirm clear benefits from treatment with removab(R) for patients with malignant ascites
|
|
17 Jul 2007 |
XOMA Initiates Phase I U.S. Trial in Type 2 Diabetes for XOMA 052, Monoclonal Antibody With Therapeutic Potential in Multiple Inflammatory Diseases
|
|
14 Jul 2007 |
CSL Behring Completes Enrollment for Phase III Registration Trial of Next Generation of Subcutaneous Immunoglobulin
|
|
13 Jul 2007 |
Amgen and Daiichi Sankyo announce agreement for denosumab in Japan
|
|
13 Jul 2007 |
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
|
|
13 Jul 2007 |
Phase II Study of IMC-A12 for Advanced Colorectal Cancer Has Commenced Patient Enrollment
|
|
12 Jul 2007 |
Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Lung Cancer Patients
|
|
12 Jul 2007 |
TRACON Pharmaceuticals and Micromet Announce the Initiation of Phase 1 Clinical Trial with TRC093 (D93), a Humanized Antibody for Cancer Treatment
|
|
11 Jul 2007 |
Actemra: latest phase III study shows significant improvement in symptoms of patients with rheumatoid arthritis
|
|
11 Jul 2007 |
Peregrine Pharmaceuticals Initiates Bavituximab Clinical Trial in HCV Patients Co-Infected With HIV
|
|
10 Jul 2007 |
MacroGenics IND for West Nile Virus Monoclonal Antibody is Active
|
|
03 Jul 2007 |
Ablynx announces interim results of first nanobody (R) phase i study of ALX-0081 (anti-vWF)
|
|
03 Jul 2007 |
Lexicon Develops Antibodies that Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
|
|
02 Jul 2007 |
Genmab announces final humax-CD4 Phase II CTCL data
|
|
30 Jun 2007 |
Genmab regains rights to HuMax-CD4
|
|
30 Jun 2007 |
WILEX to follow FDA advice and apply for a special protocol assessment (SPA) for CA9-SCAN
|
|
23 Jun 2007 |
Alexion's Soliris(TM) granted marketing approval in europe for treatment of all patients with PNH
|
|
22 Jun 2007 |
Viragen Streamlines Research Focus and Halts Further Development of OVA(TM) System
|
|
20 Jun 2007 |
Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
|
|
19 Jun 2007 |
Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology
|
|
16 Jun 2007 |
Actemra: Roche's novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study
|
|
16 Jun 2007 |
GlaxoSmithKlline and Genmab present positive Phase II results with ofatumumab in patients with rheumatoid arthritis (RA)
|
|
16 Jun 2007 |
GlaxoSmithKlline and Genmab present positive Phase II results with ofatumumab in patients with rheumatoid arthritis (RA)
|
|
16 Jun 2007 |
Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia(R) (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
|
|
15 Jun 2007 |
Anti-TNF golimumab continues to show promise in Phase II rheumatoid arthritis study
|
